ProPhase Labs Announces New $6 Million Stock Repurchase Plan
July 26, 2022 08:00 ET
|
ProPhase Labs, Inc.
Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
July 21, 2022 08:30 ET
|
ProPhase Labs, Inc.
Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to Discuss Business Developments Today at 11:30...
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
March 24, 2022 08:15 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
March 30, 2021 17:10 ET
|
ProPhase Labs, Inc.
New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
January 29, 2021 08:30 ET
|
ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...